Blue-BANDit™ Ready-to-Use Protein Stain - code K217-1L

MATERIAL SAFETY DATA SHEET

REVIEWED:  9-19-00

 

SECTION 1 CHEMICAL IDENTIFICATION
CODE:                  E562
NAME:    PAGE PLUS CONCENTRATE

 

SECTION 2 COMPOSITION/INFORMATION ON INGREDIENTS
THE HAZARDOUS COMPONENTS OF THIS PRODUCT ARE AS FOLLOWS:
CHEMICAL NAME           CAS #: RTECS #:   %:
ACRYLAMIDE   79-06-1 AS3325000 35-40
SEE ACTUAL ENTRY IN RTECS FOR COMPLETE INFORMATION.

 

SECTION 3 HAZARDS IDENTIFICATION

LABEL PRECAUTIONARY STATEMENTS

POISON MAY CAUSE CANCER.

NEUROTOXIN MAY CAUSE HERITABLE GENETIC DAMAGE, MAY IMPAIR FERTILITY.

TOXIC IN CONTACT WITH SKIN AND IF SWALLOWED.

IRRITATING TO EYES AND SKIN.

MAY CAUSE SENSITIZATION BY INHALATION AND SKIN CONTACT.

READILY ABSORBED THROUGH SKIN.

TARGET ORGAN(S): NERVES, KIDNEYS

AVOID EXPOSURE - OBTAIN SPECIAL INSTRUCTIONS BEFORE USE.

IN CASE OF ACCIDENT OR IF YOU FEEL UNWELL, SEEK MEDICAL ADVICE IMMEDIATELY (SHOW THE LABEL WHERE POSSIBLE).

WEAR SUITABLE PROTECTIVE CLOTHING, GLOVES AND EYE/FACE PROTECTION.

DO NOT BREATHE VAPOR.

 

SECTION 4 FIRST-AID MEASURES

IN CASE OF CONTACT, IMMEDIATELY FLUSH EYES OR SKIN WITH COPIOUS AMOUNTS OF WATER FOR AT LEAST 15 MINUTES WHILE REMOVING CONTAMINATED CLOTHING AND SHOES.

IF INHALED, REMOVE TO FRESH AIR. IF NOT BREATHING GIVE ARTIFICIAL RESPIRATION. IF BREATHING IS DIFFICULT, GIVE OXYGEN.

IF SWALLOWED, WASH OUT MOUTH WITH WATER PROVIDED PERSON IS CONSCIOUS.

CALL A PHYSICIAN IMMEDIATELY.

WASH CONTAMINATED CLOTHING BEFORE REUSE.

 

SECTION 5 FIRE FIGHTING MEASURES

EXTINGUISHING MEDIA

CARBON DIOXIDE, DRY CHEMICAL POWDER OR APPROPRIATE FOAM.

SPECIAL FIREFIGHTING PROCEDURES

WEAR SELF-CONTAINED BREATHING APPARATUS AND PROTECTIVE CLOTHING TO PREVENT CONTACT WITH SKIN AND EYES.

USE WATER SPRAY TO COOL FIRE-EXPOSED CONTAINERS.

UNUSUAL FIRE AND EXPLOSIONS HAZARDS

CONTAINER EXPLOSION MAY OCCUR UNDER FIRE CONDITIONS.

EMITS TOXIC FUMES UNDER FIRE CONDITIONS.

 

SECTION 6 ACCIDENTAL RELEASE MEASURES

EVACUATE AREA.

WEAR SELF-CONTAINED BREATHING APPARATUS, RUBBER BOOTS AND HEAVY RUBBER GLOVES.

ABSORB ON SAND OR VERMICULITE AND PLACE IN CLOSED CONTAINERS FORDISPOSAL.

VENTILATE AREA AND WASH SPILL SITE AFTER MATERIAL PICKUP IS COMPLETE.

 

SECTION 7 HANDLING AND STORAGE

REFER TO SECTION 8.

 

SECTION 8 EXPOSURE CONTROLS/PERSONAL PROTECTION

WEAR APPROPRIATE NIOSH/MSHA-APPROVED RESPIRATOR, CHEMICAL-RESISTANT GLOVES, SAFETY GOGGLES, OTHER PROTECTIVE CLOTHING.

USE ONLY IN A CHEMICAL FUME HOOD.

SAFETY SHOWER AND EYE BATH.

DO NOT BREATHE VAPOR.

DO NOT GET IN EYES, ON SKIN, ON CLOTHING.

AVOID PROLONGED OR REPEATED EXPOSURE.

WASH THOROUGHLY AFTER HANDLING.

KEEP TIGHTLY CLOSED.

STORE IN A COOL DRY PLACE.

 

SECTION 9 PHYSICAL AND CHEMICAL PROPERTIE

APPEARANCE AND ODOR LIQUID.

 

SECTION 10 STABILITY AND REACTIVITY

STABILITY: UNSTABLE.

CONDITIONS TO AVOID: DO NOT HEAT OVER 50 DEGREES C

INCOMPATIBILITIES: AVOID CONTACT WITH ACID.

BASES: OXIDIZING AGENTS, REDUCING AGENTS, IRON AND IRON SALTS, COPPER, ALUMINUM, BRASS, FREE RADICAL INITIATORS

AIR SENSITIVE

STORE AWAY FROM HEAT AND DIRECT SUNLIGHT. MAY POLYMERIZE ON EXPOSURE TO LIGHT.

HAZARDOUS COMBUSTION OR DECOMPOSITION PRODUCTS TOXIC FUMES OF CARBON MONOXIDE, CARBON DIOXIDE, NITROGEN OXIDES, AMMONIA

HAZARDOUS POLYMERIZATION MAY OCCUR.

CONDITIONS TO AVOID: DO NOT HEAT OVER 50 DEGREES C

 

SECTION 11 TOXICOLOGICAL INFORMATION

ACUTE EFFECTS: TOXIC IF SWALLOWED OR ABSORBED THROUGH SKIN. MAY BE HARMFUL IF INHALED. CAUSES EYE AND SKIN IRRITATION. MATERIAL MAY BE IRRITATING TO MUCOUS MEMBRANES AND UPPER RESPIRATORY TRACT. READILY ABSORBED THROUGH SKIN. MAY CAUSE ALLERGIC REACTION.

TARGET ORGAN(S): NERVES, KIDNEYS

CHRONIC EFFECTS: THIS PRODUCT IS OR CONTAINS A COMPONENT THAT HAS BEEN REPORTED TO BE PROBABLY CARCINOGENIC BASED ON ITS IARC, OSHA, ACGIH, NTP OR EPA

CLASSIFICATION: MAY ALTER GENETIC MATERIAL, MAY CAUSE REPRODUCTIVE DISORDERS.

ADDITIONAL INFORMATION: ACRYLAMIDE TOXICITY IS MANIFESTED AS A SENSORIMOTOR PERIPHERAL NEUROPATHY. SYMPTOMS INCLUDE: DROWSINESS, LOSS OF BALANCE, CONFUSION, MEMORY LOSS, HALLUCINATIONS, NUMBNESS, PARESTHESIAS (ATAXIA, TREMOR, DYSARTHRIA) AND INCOORDINATION.

RTECS #: AS3325000

ACRYLAMIDE IRRITATION DATA

SKN-RBT 50 MG/3D MLD  

TXAPA9 6,172,1964

SKN-RBT 500 MG/24H MLD

85JCAE -,337,1986

EYE-RBT 10 MG/30S RINSE MLD

TXAPA9 6,172,1964

EYE-RBT 100 MG/24H MOD 

28ZPAK -,54,1972

TOXICITY DATA

ORL-RAT LD50:124 MG/KG 

AMPMAR 36,58,1975

SKN-RAT LD50:400 MG/KG  

GISAAA 44(10),73,1979

IPR-RAT LD50:90 MG/KG

AMPMAR 36,58,1975

UNR-RAT LD50:208 MG/KG

GISAAA 43(9),38,1978

ORL-MUS LD50:107 MG/KG

ARTODN 47,179,1981

IPR-MUS LD50:170 MG/KG

TXAPA9 33,142,1975

UNR-MUS LD50:156 MG/KG

GISAAA 43(9),38,1978

ORL-RBT LD50:150 MG/KG

TXAPA9 6,172,1964

SKN-RBT LD50:1680 UL/KG

ATDAEI 1,115,1990

UNR-RBT LD50:280 MG/KG

GISAAA 43(9),38,1978

ORL-GPG LD50:150 MG/KG

TXAPA9 6,172,1964

SCU-GPG LD50:170 MG/KG

MELAAD 47,192,1956

UNR-GPG LD50:173 MG/KG

GISAAA 43(9),38,1978

ORL-QAL LD50:186 MG/KG

JTEHD6 7,935,1981

ORL-MAM LD50:100 MG/KG

KASEAA 17,495,1979

TARGET ORGAN DATA:

PERIPHERAL NERVE AND SENSATION (FLACCID PARALYSIS WITHOUT ANESTHESIA)

BEHAVIORAL (ALTERED SLEEP TIME)

BEHAVIORAL (TREMOR)

BEHAVIORAL (CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD)

BEHAVIORAL (CHANGE IN MOTOR ACTIVITY)

BEHAVIORAL (MUSCLE CONTRACTION OR SPASTICITY)

LUNGS, THORAX OR RESPIRATION (TUMORS)

GASTROINTESTINAL (NAUSEA OR VOMITING)

BLOOD (OTHER CHANGES)

SKIN AND APPENDAGES (TUMORS)

PATERNAL EFFECTS (SPERMATOGENESIS)

PATERNAL EFFECTS (TESTES, EPIDIDYMIS, SPERM DUCT)

MATERNAL EFFECTS (PARTURITION)

EFFECTS ON FERTILITY (MALE FERTILITY INDEX)

EFFECTS ON FERTILITY (PRE-IMPLANTATION MORTALITY)

EFFECTS ON FERTILITY (POST-IMPLANTATION MORTALITY)

EFFECTS ON EMBRYO OR FETUS (FETOTOXICITY)

EFFECTS ON EMBRYO OR FETUS (FETAL DEATH)

SPECIFIC DEVELOPMENTAL ABNORMALITIES (MUSCULOSKELETAL SYSTEM)

TUMORIGENIC EFFECTS (TESTICULAR TUMORS)

TUMORIGENIC EFFECTS (UTERINE TUMORS)

EFFECTS ON NEWBORN (STILLBIRTH)

EFFECTS ON NEWBORN (VIABILITY INDEX)

EFFECTS ON NEWBORN (GROWTH STATISTICS)

EFFECTS ON NEWBORN (BIOCHEMICAL AND METABOLIC)

EFFECTS ON NEWBORN (BEHAVIORAL)

TUMORIGENIC (CARCINOGENIC BY RTECS CRITERIA)

TUMORIGENIC (NEOPLASTIC BY RTECS CRITERIA)

BIOCHEMICAL EFFECTS (TRANSAMINASES)

BIOCHEMICAL EFFECTS (PEPTIDASES)

ADDITIONAL INFORMATION

SKN-RBT LD50:252 MG/KG

ONLY SELECTED REGISTRY OF TOXIC EFFECTS OF CHEMICAL SUBSTANCES (RTECS) DATA IS PRESENTED HERE. SEE ACTUAL ENTRY IN RTECS FOR COMPLETE INFORMATION.

 

SECTION 12 ECOLOGICAL INFORMATION

DATA NOT YET AVAILABLE.

 

SECTION 13 DISPOSAL CONSIDERATIONS

DISSOLVE OR MIX THE MATERIAL WITH A COMBUSTIBLE SOLVENT AND BURN IN A CHEMICAL INCINERATOR EQUIPPED WITH AN AFTERBURNER AND SCRUBBER.

OBSERVE ALL FEDERAL, STATE AND LOCAL ENVIRONMENTAL REGULATIONS.

 

SECTION 14 TRANSPORT INFORMATION

UN#:  2810

PROPER SHIPPING NAME:  TOXIC LIQUID, ORGANIC, N.O.S., ( CONTAINS ACRYLAMIDE)

PG:  III

CLASS:  6.1

 

SECTION 15 REGULATORY INFORMATION

EUROPEAN INFORMATION

EC INDEX NO:     616-003-00-0

TOXIC  R: 40

POSSIBLE RISK OF IRREVERSIBLE EFFECTS.   R 45

MAY CAUSE CANCER. R: 26/27/28

VERY TOXIC BY INHALATION, IN CONTACT WITH SKIN AND IF SWALLOWED.

S:  36/37/39

WEAR SUITABLE PROTECTIVE CLOTHING, GLOVES AND EYE/FACE PROTECTION.

REVIEWS, STANDARDS, AND REGULATIONS

OEL=MAK

ACGIH TLV-ANIMAL CARCINOGEN  

DTLVS* TLV/BEI,1996

ACGIH TLV-TWA 0.03 MG/M3 (SKIN) 

DTLVS* TLV/BEI,1996

IARC CANCER REVIEW

ANIMAL SUFFICIENT EVIDENCE IMEMDT 39,41,1986

IARC CANCER REVIEW

ANIMAL SUFFICIENT EVIDENCE IMEMDT 60,389,1994

IARC CANCER REVIEW

HUMAN NO ADEQUATE DATA IMEMDT 39,41,1986

IARC CANCER REVIEW

HUMAN INADEQUATE EVIDENCE IMEMDT 60,389,1994

IARC CANCER REVIEW

GROUP 2A IMEMDT 60,389,1994

MSHA STANDARD-AIR

TWA 0.3 MG/M3 (SKIN) DTLVS* 3,5,1971

OSHA PEL (GEN INDU)

8H TWA 0.3 MG/M3 (SKIN) CFRGBR 29,1910.1000,1994

OSHA PEL (CONSTRUC)

8H TWA 0.3 MG/M3 (SKIN) CFRGBR 29,1926.55,1994

OSHA PEL (SHIPYARD)

8H TWA 0.3 MG/M3 (SKIN) CFRGBR 29,1915.1000,1993

OSHA PEL (FED CONT)

8H TWA 0.3 MG/M3 (SKIN) CFRGBR 41,50-204.50,1994

OEL-AUSTRALIA

TWA 0.3 MG/M3;SKIN; CARCINOGEN JAN 1993

OEL-BELGIUM

TWA 0.3 MG/M3;SKIN; CARCINOGEN JAN 1993

OEL-DENMARK

TWA 0.3 MG/M3;SKIN; CARCINOGEN JAN 1993

OEL-FINLAND

TWA 0.3 MG/M3;STEL 0.9 MG/M3  JAN 1993

OEL-FRANCE

TWA 0.3 MG/M3 JAN 1993

OEL-GERMANY

SKIN CARCINOGEN JAN 1993

OEL-HUNGARY

STEL 0.3 MG/M3;SKIN;  CARCINOGEN JAN 1993

OEL-JAPAN

TWA 0.3 MG/M3;SKIN JAN 1993

OEL-THE NETHERLANDS

TWA 0.3 MG/M3 JAN 1993

OEL-THE PHILIPPINES

TWA 0.3 MG/M3;SKIN JAN 1993

OEL-RUSSIA

STEL 0.2 MG/M3;SKIN JAN 1993

OEL-SWEDEN

TWA 0.3 MG/M3;STEL 0.9 MG/M3;SKIN JAN 1993

OEL-SWITZERLAND

TWA 0.3 MG/M3;SKIN;CARCINOGEN JAN 1993

OEL-UNITED KINGDOM

TWA 0.3 MG/M3;STEL 0.6 MG/M3;SKIN JAN 1993

OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA CHECK ACGIH TLV

OEL IN NEW ZEALAND, SINGAPORE, VIETNAM CHECK ACGIH TLV

NIOSH REL TO ACRYLAMIDE-AIR:10H CA TWA 0.03 MG/M3 (SK)

NIOSH* DHHS #92-100,1992

NOHS 1974: HZD 03540; NIS 10; TNF 442; NOS 24; TNE 7047

NOES 1983: HZD 03540; NIS 19; TNF 453; NOS 22; TNE 10651; TFE 721

EPA GENETOX PROGRAM 1988, POSITIVE: CYTOGENETICS-MALE GERM CELL

EPA GENETOX PROGRAM 1988, NEGATIVE: IN VIVO CYTOGENETICS-NONHUMAN BONE MARROW

EPA GENETOX PROGRAM 1988, INCONCLUSIVE: IN VIVO SCE-NONHUMAN

EPA TSCA SECTION 8(B) CHEMICAL INVENTORY

EPA TSCA 8(A) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULEFEREAC 47,26992,82

EPA TSCA SECTION 8(D) UNPUBLISHED HEALTH/SAFETY STUDIES ON EPA IRIS DATABASE

EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, APRIL 1997

NTP 7TH ANNUAL REPORT ON CARCINOGENS, 1992 : ANTICIPATED TO BE CARCINOGEN

OSHA ANALYTICAL METHOD #21  U.S. INFORMATION

THIS PRODUCT IS SUBJECT TO SARA SECTION 313 REPORTING REQUIREMENTS.

CALIFORNIA PROPOSITION 65:

THIS PRODUCT IS OR CONTAINS CHEMICAL(S) KNOWN TO THE STATE OF CALIFORNIA TO CAUSE CANCER.

 

SECTION 16 OTHER INFORMATION

THE ABOVE INFORMATION IS BELIEVED TO BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL BE USED ONLY AS A GUIDE.

AMRESCO INC.SHALL NOT BE HELD LIABLE FOR ANY DAMAGE RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE PRODUCT.

SEE REVERSE SIDE OF INVOICE OR PACKING SLIP FOR ADDITIONAL TERMS AND CONDITIONS OF SALE.

 

211 Bis Avenue Kennedy - BP 1140

03103 Montluçon cedex - France

tel (33) (0) 4 70 03 88 55 

fax (33) (0) 4 70 03 82 60

interbiotech@interchim.com

 http://www.interchim.com

Vos contacts:

Etienne Boireau - Olivier Cadas - Olivier Alméras

 

hot line  33 (0) 4 70 03 73 06